Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.78	69.97	110.69
Graham Fair Price	3.09	38.89	37.72
PEG	310.59	6.47	1.58
Price/Book	-27.45	6.20	8.55
Price/Cash Flow	385.31	-412.05	84.90
Prices/Earnings	-29.07	28.14	39.67
Price/Sales	-31.24	38.61	56.16
Price/FCF	385.31	-412.05	84.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.60	0.81	0.79
Operating Margin	11.85	0.44	0.39
ROA	9.06	0.04	0.03
ROE	0.05	0.06	2.29
ROIC	0.04	0.05	7.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	214.32
Dividends QOQ	0.02	0.07	320.70
EBIT QOQ	0.14	0.20	41.39
EPS QOQ	0.25	0.04	-82.73
FCF QOQ	1.06	-1.15	8.44
Revenue QOQ	0.14	0.08	-46.65
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-216.87	-222.81	-2.74
Days Sales Outstanding (DSO)	355.78	324.34	-8.84
Inventory Turnover	-0.41	-0.40	2.67
Debt/Capitalization	0.11	0.11	-3.48
Quick Ratio	2.21	2.38	8.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.27	34.93	1.93
Cash	13.44	11.49	-14.48
Capex	-0.35	-0.40	-13.18
Free Cash Flow	3.45	-0.53	-84.76
Revenue	5.21	5.61	7.55
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.31	2.50	8.42
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.34	-3.08	29.08
Naive Interpretation	Member

06 - Financial Health · Bad

Rating